InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Odegard Valerie, Chief Executive Officer. Officer active across 1 companies, notably Silverback Therapeutics, Inc.. Cumulatively, 3 filings have been recorded. The latest transaction was disclosed on 2 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
045,233 shares0
Common Stock
SEC:0001209191-22-027158:0·
016,406 shares0
Common Stock
SEC:0001209191-22-006434:0·
016,406 shares0
Common Stock
SEC:0001209191-22-006434·
3 of 3 declarations
About Odegard Valerie
Valerie Odegard is the CEO and Chief Strategy Officer at Silverback Therapeutics, Inc. She is responsible for the strategic leadership of the company, overseeing operations and growth initiatives. Her leadership is crucial for Silverback's success in the biopharmaceutical sector.
